ECE2022 Poster Presentations Diabetes, Obesity, Metabolism and Nutrition (202 abstracts)
Comparing global rating scores from simulation-based diabetes and endocrine scenarios between healthcare professionals of high- and low- and middle-income countries
Zakee Abdi 1,2 , Dengyi Zhou 3 , Kashish Malhotra 4 , Anisah Ali 3 , Jameela Sheikh 3 , Pavithra Sakthivel 3 , Emily Warmington 3 , Carina Synn Cuen Pan 3 , Wentin Chen 3 , Harjeet Kaur 3 , Rachel Nirmal 3 , Vina Soran 3 , Isabel Allison 3 , Nia Evans 5 , Dwi Delson 6 , Meri Davitadze 7 , Punith Kempegowda 3,8 & Simba Simulation 3,8
1Medical University of Plovdiv, Plovdiv, Bulgaria; 2School of Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; 3College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; 4Dayanand Medical College and Hospital, Punjab, India; 5Royal Glamorgan Hospital, Cwm Taf Morgannwg University Health Board, Rhondda Cynon Taff, UK; 6School of Medicine, University of Dundee, Dundee, UK; 7Georgian-American Family Medicine Clinic ’Medical House’, Tbilisi, Georgia; 8Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Background: Simulation via Instant Messaging - Birmingham Advance (SIMBA) is an online simulation learning modality designed to recreate clinical scenarios, allowing participants to increase their confidence in a safe environment without compromising patient safety. The global rating scale (GRS) is a commonly used assessment tool in medical schools to assess participant competence and skills. Following SIMBA sessions, an independent assessor anonymously scores participants’ performance of their simulated case using an adapted version of the GRS.
Objective: To study the pattern of GRS score across various domains of endocrine scenarios and the variation by country of residence.
Methods: We included all diabetes and endocrine SIMBA sessions conducted from July 2020 to October 2021. The participants’ responses were divided into various domains and each domain was scored from 1 (poor) to 5 (excellent). Data were pooled during analysis and findings are reported as frequencies. Chi-square test was used to compare the differences between participants’ performance across various domains. Participants were further grouped by the country’s income according to the country of residence based on the 2022 World Bank Report: high-income countries (HICs) and low- and middle-income countries (LMICs).
Results: 293 healthcare professionals participated in six SIMBA sessions (thyroid, pituitary, diabetes, metabolic bone, gonadal, and diabetic microvascular complications). The median (IQR) GRS scores for domains are as follows: history-taking: 4.0 (3.0–5.0), physical examination: 4.0 (3.0–4.6), investigations requested: 3.3 (3.0–4.0), results’ interpretation: 2.6 (1.6–3.3), clinical judgement: 3.3 (2.6–4.0) and management and follow-up: 2.6 (2.0–3.3). HICs and LMICs (31.2%, n=91) scored similarly in history-taking (HIC: 3.81 vs LMIC: 3.79;P=0.05), physical examination (HIC: 3.67 vs LMIC: 3.68;P=0.19), investigations requested (HIC: 3.35 VS LMIC: 3.33;P=0.27), and results’ interpretation (HIC: 2.63 vs LMIC: 2.61;P=0.74). HICs scored better in clinical judgement (HIC: 3.23 vs LMIC: 3.18;P=0.008) and providing management and follow-up plans (HIC: 2.66 vs LMIC: 2.64;P=0.001).
Conclusion: All participants, particularly those from LMICs, scored lower in the categories of investigations, clinical judgement, and management skills. This demonstrates the need for targeted educational programmes which can be both cost-effective and beneficial to all participants independent of country of residence.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more